According to our latest research, the global Methocarbamol market size reached USD 706.1 million in 2025, reflecting robust demand across key therapeutic applications. The market is expected to grow at a CAGR of 4.7% during the forecast period, reaching approximately USD 1,058.4 million by 2034. This growth is primarily driven by the increasing prevalence of musculoskeletal disorders, rising awareness regarding muscle relaxant therapies, and the expanding geriatric population globally. As per our most recent analysis, the market is witnessing significant momentum due to the rising adoption of Methocarbamol in both acute and chronic muscle spasm management, as well as the broader shift toward affordable generic therapies across diverse healthcare systems. https://growthmarketreports.com/report/methocarbamol-market